Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-01-04 Option Award | 2024-01-08 4:39 pm | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | Silberman David Chief Financial Officer | 136,500 | $0 | 366,500 (Direct) | View |
| 2023-05-26 Option Award | 2023-05-31 5:10 pm | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | Silberman David Chief Financial Officer | 24,500 | $0 | 230,000 (Direct) | View |
| 2023-04-17 Option Award | 2023-04-20 06:00 am | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | Silberman David Chief Financial Officer | 97,500 | $0 | 205,500 (Direct) | View |
| 2022-07-28 Option Award | 2022-08-01 8:00 pm | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | Silberman David Chief Financial Officer | 39,000 | $0 | 108,000 (Direct) | View |
| 2022-01-03 Option Award | 2022-01-05 8:32 pm | N/A 2032-01-03 | ORAMED PHARMACEUTICALS INC. | ORMP | Silberman David Chief Financial Officer | 51,000 | $0 | 101,000 (Direct) | View |
| 2021-09-01 Option Award | 2021-09-02 4:48 pm | N/A 2031-09-01 | ORAMED PHARMACEUTICALS INC. | ORMP | Silberman David Chief Financial Officer | 50,000 | $0 | 100,000 (Direct) | View |